Gemcitabine increases efficacy of standard chemo for NSCLC
KeywordsLung Cancer Survival Time Median Survival Gemcitabine Partial Response
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 2006